Skip to main content

Table 4 Visual outcome

From: Immune recovery uveitis in HIV patients with cytomegalovirus retinitis in the era of HAART therapy—a 5-year study from Singapore

Number of affected eyes, n

53

Range of VA at IRU presentation, n (%)

 6/6 to 6/12

34 (64.2 %)

 6/15 to 6/45

12 (22.6 %)

 6/60 or worse

7 (13.2 %)

Range of VA at 6-month follow-up post IRU diagnosis, n (%)

 6/6 to 6/12

35 (66.0 %)

 6/15 to 6/45

10 (18.9 %)

 6/60 or worse

8 (15.1 %)

VA change from IRU diagnosis to 6-month follow-up, n (%)

 Worsen by at least 3 lines

6 (11.3 %)

 Worsen by 2 lines

2 (3.8 %)

 Worsen by 1 line

6 (11.3 %)

 No change

18 (34.0 %)

 Improved by 1 line

7 (13.2 %)

 Improved by 2 lines

6 (11.3 %)

 Improved by at least 3 lines

8 (15.1 %)